Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Sponsor: M.D. Anderson Cancer Center
Terminated
IRB Study Closure
Listed as NCT04835597, this observational or N/A phase trial focuses on Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage IA Breast Cancer AJCC v8 and remains terminated or withdrawn. Sponsored by M.D. Anderson Cancer Center, it has been updated 8 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2023 — Apr 2024 [monthly]
Recruiting
-
Feb 2023 — Oct 2023 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Nov 2022 — Feb 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Nov 2022 [monthly]
Not Yet Recruiting
-
May 2021 — May 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .